290 related articles for article (PubMed ID: 29371376)
1. Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.
Huang CY; Yang YH; Lin LY; Tsai CT; Hwang JJ; Chen PC; Lin JL
Heart; 2018 Aug; 104(15):1276-1283. PubMed ID: 29371376
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis.
Lin TT; Yang YH; Liao MT; Tsai CT; Hwang JJ; Chiang FT; Chen PC; Lin JL; Lin LY
Kidney Int; 2015 Aug; 88(2):378-85. PubMed ID: 25807037
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.
Disertori M; Barlera S; Staszewsky L; Latini R; Quintarelli S; Franzosi MG
Cardiovasc Drugs Ther; 2012 Feb; 26(1):47-54. PubMed ID: 22009136
[TBL] [Abstract][Full Text] [Related]
5. Interactions Among Vitamin D, Atrial Fibrillation, and the Renin-Angiotensin-Aldosterone System.
Turin A; Bax JJ; Doukas D; Joyce C; Lopez JJ; Mathew V; Pontone G; Shah F; Singh S; Wilber DJ; Rabbat MG
Am J Cardiol; 2018 Sep; 122(5):780-784. PubMed ID: 30057228
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews.
Yu Z; Zhang D; Ji Q; Yi F
Medicine (Baltimore); 2021 May; 100(18):e25559. PubMed ID: 33950930
[TBL] [Abstract][Full Text] [Related]
7. Association of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists use with risk of atrial fibrillation after pacemaker implantation among very old patients.
Lin D; Wu C; Jiang Y; Li Y; Zhang X; Wang Y
Biosci Trends; 2022 Jan; 15(6):390-396. PubMed ID: 34866125
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
[TBL] [Abstract][Full Text] [Related]
9. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
Egido JJ; Gomez R; Romero SP; Andrey JL; Ramirez D; Rodriguez A; Pedrosa MJ; Gomez F
Int J Clin Pract; 2019 Jun; 73(6):e13317. PubMed ID: 30694579
[TBL] [Abstract][Full Text] [Related]
10. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.
Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
J Am Coll Cardiol; 2005 Jun; 45(11):1832-9. PubMed ID: 15936615
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and hypertrophic cardiomyopathy].
Liu YY; Du X; He L; Hu R; Ning M; Lyu J; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jan; 50(1):62-67. PubMed ID: 35045616
[No Abstract] [Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation in heart failure patients: An update on renin-angiotensin-aldosterone system pathway blockade as a therapeutic and prevention target.
Koniari I; Artopoulou E; Mplani V; Mulita F; Alexopoulou E; Chourdakis E; Abo-Elseoud M; Tsigkas G; Panagiotopoulos I; Kounis N; Velissaris D
Cardiol J; 2023; 30(2):312-326. PubMed ID: 35762070
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
[TBL] [Abstract][Full Text] [Related]
15. Effects of RAAS Blockers on Atrial Fibrillation Prophylaxis: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Chaugai S; Meng WY; Ali Sepehry A
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):388-404. PubMed ID: 26817632
[TBL] [Abstract][Full Text] [Related]
16. Age and CHADS2 Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation.
Hung CY; Hsieh YC; Li CH; Huang JL; Lin CH; Wu TJ
Sci Rep; 2015 Jun; 5():11442. PubMed ID: 26094981
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
Hsieh YC; Hung CY; Li CH; Liao YC; Huang JL; Lin CH; Wu TJ
Medicine (Baltimore); 2016 May; 95(20):e3721. PubMed ID: 27196491
[TBL] [Abstract][Full Text] [Related]
18. Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study.
Lin TT; Wu CK; Liao MT; Yang YH; Chen PC; Yeih DF; Lin LY
PLoS One; 2017; 12(12):e0188720. PubMed ID: 29216228
[TBL] [Abstract][Full Text] [Related]
19. Impact of renin-angiotensin-aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension.
Xu W; Yang YM; Zhu J; Wu S; Wang J; Zhang H; Shao XH
BMC Cardiovasc Disord; 2022 Apr; 22(1):141. PubMed ID: 35365067
[TBL] [Abstract][Full Text] [Related]
20. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]